MEDIPOST (078160.KQ)

MEDIPOST stock price today, ATLAS forecast and fair value

Healthcare · Biotechnology & Medical Research · KOSDAQ · South Korea

₩8,490▲ +2.41%

Prices as of Oct 27, 2026 · KRW

ATLAS fair value

ATLAS has no fair value for this stock today.

Chance of rising in 1 month

47%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on MEDIPOST in ATLAS

ATLAS's own quantitative analysis, all in one place.

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.

See everything included

Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

On MEDIPOST

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.

And for you

ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

Get started →

Plans from €3.99 a month.

ATLAS's model gives MEDIPOST a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between ₩7,547 and ₩9,355; in 9 out of 10, between ₩6,239 and ₩11,316. Estimated annual volatility is 59%.

Price, last 12 months (weekly close)

Key numbers

52-week high: ₩29,100
52-week low: ₩7,250
Revenue (12 months): ₩62.4B
Gross margin: 51.1%
Operating margin: -26.3%
Net margin: 4.4%
Beta: 0.78

What this means

ATLAS does not publish a fair value for 078160.KQ right now, but it does show its odds of rising: close to a coin flip.

Over the last 52 weeks 078160.KQ has traded between ₩7,250 and ₩29,100. Today it is 70.8% below that high and 17% above its low.

Its beta is 0.78: it tends to move less than the market.

About the company

MEDIPOST Co., Ltd. provides stem cell therapeutic solutions to meet the unmet medical needs in South Korea and internationally. It operates CELLTREE, an umbilical cord blood bank; and offers cord blood banking services to treat various incurable diseases.

Want to see everything about MEDIPOST?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What does MEDIPOST do?

What is the chance 078160.KQ goes up next month?

47%: close to a coin flip. In half of the simulated outcomes, 078160.KQ ends the month between ₩7,547 and ₩9,355.

How volatile is 078160.KQ?

ATLAS estimates annual volatility at 59%. In a typical month, half of the outcomes end between ₩7,547 and ₩9,355.

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer